The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner
暂无分享,去创建一个
M. Kiso | Y. Kawaoka | J. Inoue | J. Gohda | K. Semba | Y. Kawaguchi | Z. Matsuda | M. Imai | M. Takeda | N. Ohmagari | Y. Sakai-Tagawa | K. Iwatsuki-Horimoto | Mizuki Yamamoto | N. Kinoshita | Maki Kiso | Yuko Sakai-Tagawa
[1] Fang Li,et al. Cell entry mechanisms of SARS-CoV-2 , 2020, Proceedings of the National Academy of Sciences.
[2] Fabian J Theis,et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes , 2020, Nature Medicine.
[3] M. Müller,et al. Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19 , 2020, Antimicrobial Agents and Chemotherapy.
[4] H. Ogawa,et al. Potential of heparin and nafamostat combination therapy for COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.
[5] Qiang Sun,et al. Systemic analysis of tissue cells potentially vulnerable to SARS-CoV-2 infection by the protein-proofed single-cell RNA profiling of ACE2, TMPRSS2 and Furin proteases , 2020, bioRxiv.
[6] Dengju Li,et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy , 2020, Journal of Thrombosis and Haemostasis.
[7] Jenny Y. Zhang,et al. Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19) , 2020, Journal of Translational Medicine.
[8] B. Russ,et al. Homology Modeling of TMPRSS2 Yields Candidate Drugs That May Inhibit Entry of SARS-CoV-2 into Human Cells , 2020 .
[9] Fabian J Theis,et al. SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Enriched in Specific Cell Subsets Across Tissues , 2020, SSRN Electronic Journal.
[10] M. Shimojima,et al. The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15 , 2020, bioRxiv.
[11] Fumihiro Kato,et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells , 2020, Proceedings of the National Academy of Sciences.
[12] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[13] Wu Zhong,et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro , 2020, Cell Research.
[14] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[15] J. Inoue,et al. TRAF6 maintains mammary stem cells and promotes pregnancy-induced mammary epithelial cell expansion , 2019, Communications Biology.
[16] Yukiko Shimizu,et al. TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection , 2019, Journal of Virology.
[17] Yoshimasa Tanaka,et al. TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections , 2017, Biochimie.
[18] Makoto Takeda,et al. Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay , 2016, Antimicrobial Agents and Chemotherapy.
[19] M. Ramakrishnan. Determination of 50% endpoint titer using a simple formula. , 2016, World journal of virology.
[20] Shujun Liu,et al. Co-Expression of Foreign Proteins Tethered to HIV-1 Envelope Glycoprotein on the Cell Surface by Introducing an Intervening Second Membrane-Spanning Domain , 2014, PloS one.
[21] L. van der Hoek,et al. Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry , 2012, Journal of Virology.
[22] S. Kao,et al. Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma. , 2006, The Journal of allergy and clinical immunology.
[23] T. Kitamura,et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. , 2003, Experimental hematology.